Company Overview - Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with a diverse product line including unique national insurance drugs [2] Financial Performance - For Q1 2025, the company reported revenue of 100 million yuan, a year-on-year decrease of 0.46%, and a net loss of approximately 11.9 million yuan, a significant decline of 960.04% compared to the previous year [3] - The gross profit margin for the company stands at 66.62% [3] Market Position - As of July 3, 2023, the company's stock closed at 5.87 yuan, down 1.34%, with a rolling price-to-earnings (PE) ratio of 36.49 times, compared to the industry average PE of 54.72 times and a median of 33.17 times, placing the company at the 95th position in the industry [1][3] - The total market capitalization of the company is 5.164 billion yuan [1] Shareholding Structure - As of the Q1 2025 report, two institutions hold shares in the company, with a total of 12,476.40 million shares valued at 558 million yuan [1]
ST景峰收盘下跌1.34%，滚动市盈率36.49倍，总市值51.64亿元
Sou Hu Cai Jing·2025-07-03 08:27